GILMAN STEVEN C
SEC CIK 1379970 · EDGAR
BoughtSold
Most active insiders at SCYX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Macleod ivor | CFO | — | — |
| 2 | Tinmouth Brian Philippe | Dir | — | — |
| 3 | Sukenick Scott | CLO | — | — |
| 4 | Angulo Gonzalez David | CEO, Dir | — | — |
| 5 | Burke Steven Keith | Dir | — | — |
| 6 | Macdonald Guy | Dir | — | — |
| 7 | HANHAM ANN | Dir | — | — |
| 8 | HASTINGS DAVID C | Dir | — | — |
| 9 | ANIDO ARMANDO | Dir | — | — |
GILMAN STEVEN C made no open-market trades at SCYX in the last 12 months.
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-30 | 2025-06-26 | SCYX | SCYNEXIS INC | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +23.0K | 70.0K | +49% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +35.7K | 152.8K | +30% | $0 |
| DT | 2024-10-18 | 2024-10-16 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | $13.05 | +5,833 | 16.8K | +53% | +$76.1K |
| DT | 2024-10-18 | 2024-10-16 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale+OE | $41.36 | -5,833 | 11.0K | -35% | -$241.3K |
| DT | 2024-10-04 | 2024-10-02 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | $13.05 | +5,833 | 16.8K | +53% | +$76.1K |
| DT | 2024-10-04 | 2024-10-02 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale+OE | $40.35 | -5,833 | 11.0K | -35% | -$235.4K |
| DT | 2024-09-20 | 2024-09-18 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | $13.05 | +5,834 | 16.8K | +53% | +$76.1K |
| DT | 2024-09-20 | 2024-09-18 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale+OE | $45.54 | -5,834 | 11.0K | -35% | -$265.7K |
| DT | 2024-09-05 | 2024-09-04 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | $3.74 | +5,000 | 16.0K | +45% | +$18.7K |
| DT | 2024-09-05 | 2024-09-04 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale+OE | $48.58 | -5,000 | 11.0K | -31% | -$242.9K |
| D | 2024-06-21 | 2024-06-20 | SCYX | SCYNEXIS INC | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +23.0K | 47.0K | +96% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +30.0K | 117.1K | +34% | $0 |
| D | 2024-05-03 | 2024-05-01 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | — | +3,200 | 11.0K | +41% | — |
| 2023-06-23 | 2023-06-15 | SCYX | SCYNEXIS INC | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +10.0K | 24.0K | +71% | $0 | |
| D | 2023-06-08 | 2023-06-06 | AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +30.0K | 87.1K | +53% | $0 |
| D | 2023-04-28 | 2023-04-27 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | — | +2,600 | 7,800 | +50% | — |
| D | 2022-06-22 | 2022-06-17 | SCYX | SCYNEXIS INC | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +10.0K | 14.0K | +250% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +13.7K | 57.1K | +32% | $0 |
| 2022-06-07 | 2022-06-03 | AKBA | Akebia Therapeutics, Inc. | GILMAN STEVEN C | Dir | S - Sale | $0.36 | -4,567 | 43.4K | -10% | -$1,644 | |
| 2022-05-02 | 2022-04-29 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale | $30.94 | -900 | 5,200 | -15% | -$27.8K | |
| D | 2022-04-29 | 2022-04-27 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | — | +2,600 | 6,100 | +74% | — |
| D | 2021-12-01 | 2021-11-29 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | $3.74 | +5,000 | 8,500 | +143% | +$18.7K |
| D | 2021-12-01 | 2021-11-29 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale+OE | $39.17 | -5,000 | 3,500 | -59% | -$195.8K |
| D | 2021-10-28 | 2021-10-27 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale+OE | $50.57 | -5,000 | 3,500 | -59% | -$252.8K |
| D | 2021-10-28 | 2021-10-27 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | $3.74 | +5,000 | 8,500 | +143% | +$18.7K |
| D | 2021-10-01 | 2021-09-30 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | M - OptEx | $3.74 | +5,000 | 8,500 | +143% | +$18.7K |
| D | 2021-10-01 | 2021-09-30 | VCEL | Vericel Corp | GILMAN STEVEN C | Dir | S - Sale+OE | $48.85 | -5,000 | 3,500 | -59% | -$244.2K |
Purchase Sale Sale after option exercise All abbreviations